Key Drivers
- Quarterly Recovery
- Strong Liquidity
- Legacy Losses
AIAI Summary
Centene has shifted from a cheap enrollment-growth turnaround to a margin-execution story: after its rally into the mid-$60s, investors should require sustained proof that pricing and medical-cost discipline can offset a projected 9% Medicaid membership decline, as policy or utilization setbacks could quickly reverse the recovery.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Quarterly Recovery
- •Strong Liquidity
- •Legacy Losses
CNC's strong quarterly profit, cash flow, and net cash position signal recovery, but 2025 losses, leverage, intangibles, and a less-cheap valuation warrant caution.
Price Behavior
Key Price Behavior Insights:
- •Weakening Momentum
- •Key Support
- •Upside Trigger
CNC remains modestly positive over the last month but faces near-term pressure below key averages, with $64.00–$64.60 support and a move above $67.70 needed to revive upside toward $69.41.
Sharp 6.2% pullback from $69.41 to $65.11 in four sessions
Sentiment & News
Key News Insights:
- •Earnings Momentum
- •Valuation Appeal
- •Medicaid Pressure
Centene's turnaround momentum, stronger pricing, and improving estimates support a constructive outlook, though Medicaid attrition remains a key risk.
Positive fundamentals may sustain investor interest, but membership declines could limit further upside
Similar Companies in Healthcare
Other companies in the same sector with AI ratings